Acute Respiratory Distress Syndrome, Conventional Mechanical Ventilation, High Frequency Oscillation Ventilation
Conditions
Brief summary
Acute respiratory distress syndrome (ARDS) in neonates has been defined in 2017.The death rate is over 50%. HFOV and CMV are two main invasive ventilation strategies. However, which one is better needing to be further elucidated.
Detailed description
Severe acute respiratory distress syndrome (ARDS) is one of the serious complications in critically ill neonates. It can result in severe hypoxemia refractory to mechanical ventilation. Usually, invasive ventilation with low parameters is enough for neonates with mild and moderate ARDS. And extracorporeal membrane oxygenation is used to neonates with severe ARDS. However, extracorporeal membrane oxygenation can also lead to high death rate and need more technique and conditions. Mechanical ventilation with higher parameters was a substitute for such situations, but the death rate, complications and injuries of higher parameters is unknown. The purpose of the present study was to compare HFOV with CMV as invasive respiratory support strategies on decrease the mortality and morbidities in neonate with ARDS.
Interventions
Ventilated infants were randomized to HFOV
Ventilated infants were randomized to CMV.
Sponsors
Study design
Intervention model description
When the neonate had fulfilled the included criteria, selective HFOV or CMV were started immediately on the basis of the group assignment.
Eligibility
Inclusion criteria
* Gestational age (GA) between 25+0 and 34+0 weeks; * Assisted with CMV within 12 h after birth; * Diagnosis with ARDS; * Stabilization for 2 hours before randomization: FiO2 0.40, mean airway pressure (MAP) 10-14 cmH2O, ≤ 40 bpm of respiratory rate, 90%-94% of SpO2, pH \> 7.20, PaCO2 60 mmHg and \> 35% of hematocrit
Exclusion criteria
* parents' decision not to participate; * Major congenital anomalies or chromosomal abnormalities; * Upper respiratory tract abnormalities; * need for surgery before randomization; * Grade Ⅲ-IV-intraventricular hemorrhage (IVH).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| the incidence of bronchopulmonary dysplasia (BPD) | 28 days after birth or 36 weeks'gestational age | the included neonate was diagnosed with BPD |
| Death | 28 days after birth or 36 weeks'gestational age or before discharge | the included preterm infants were dead |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Intraventricular hemorrhage | 28 days after birth or 36 weeks'gestational age or before discharge | Intraventricular hemorrhage was diagnosed |
| the incidence of neonatal necrotizing enterocolitis(NEC) | 28 days after birth or 36 weeks'gestational age or before discharge | the included neonate was diagnosed with NEC |
| the incidence of airleak | 28 days after birth or 36 weeks'gestational age or before discharge | the included neonate was diagnosed with airleak |
| composite mortality/BPD | 28 days after birth or 36 weeks'gestational age or before discharge | composite mortality/BPD was diagnosed |
| the incidence of retinopathy of prematurity(ROP) | 28 days after birth or 36 weeks'gestational age or before discharge | the included neonate was diagnosed with ROP |
Countries
China